|
1
|
Ren H, Han M, Zhou J, Zheng ZF, Lu P, Wang
JJ, Wang JQ, Mao QJ, Gao JQ and Ouyang HW: Repair of spinal cord
injury by inhibition of astrocyte growth and inflammatory factor
synthesis through local delivery of flavopiridol in PLGA
nanoparticles. Biomaterials. 35:6585–6594. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Anjum A, Yazid MD, Fauzi Daud M, Idris J,
Ng AMH, Selvi Naicker A, Ismail OHR, Athi Kumar RK and Lokanathan
Y: Spinal cord injury: Pathophysiology, multimolecular
interactions, and underlying recovery mechanisms. Int J Mol Sci.
21:75332020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Y, Al Mamun A, Yuan Y, Lu Q, Xiong
J, Yang S, Wu C, Wu Y and Wang J: Acute spinal cord injury:
Pathophysiology and pharmacological intervention (Review). Mol Med
Rep. 23:4172021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kawabata S, Takano M, Numasawa-Kuroiwa Y,
Itakura G, Kobayashi Y, Nishiyama Y, Sugai K, Nishimura S, Iwai H,
Isoda M, et al: Grafted Human iPS cell-derived oligodendrocyte
precursor cells contribute to robust remyelination of demyelinated
axons after spinal cord injury. Stem Cell Reports. 6:1–8. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang HY, Wang ZG, Wu FZ, Kong XX, Yang J,
Lin BB, Zhu SP, Lin L, Gan CS, Fu XB, et al: Regulation of
autophagy and ubiquitinated protein accumulation by bFGF promotes
functional recovery and neural protection in a rat model of spinal
cord injury. Mol Neurobiol. 48:452–464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Assinck P, Duncan GJ, Plemel JR, Lee MJ,
Stratton JA, Manesh SB, Liu J, Ramer LM, Kang SH, Bergles DE, et
al: Myelinogenic plasticity of oligodendrocyte precursor cells
following spinal cord contusion injury. J Neurosci. 37:8635–8654.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kim M, Kim KH, Song SU, Yi TG, Yoon SH,
Park SR and Choi BH: Transplantation of human bone marrow-derived
clonal mesenchymal stem cells reduces fibrotic scar formation in a
rat spinal cord injury model. J Tissue Eng Regen Med.
12:e1034–e1045. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Itoh N and Ohta H: Fgf10: A
paracrine-signaling molecule in development, disease, and
regenerative medicine. Curr Mol Med. 14:504–509. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chao CM, Moiseenko A, Zimmer KP and
Bellusci S: Alveologenesis: Key cellular players and fibroblast
growth factor 10 signaling. Mol Cell Pediatr. 3:172016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li YH, Fu HL, Tian ML, Wang YQ, Chen W,
Cai LL, Zhou XH and Yuan HB: Neuron-derived FGF10 ameliorates
cerebral ischemia injury via inhibiting NF-κB-dependent
neuroinflammation and activating PI3K/Akt survival signaling
pathway in mice. Sci Rep. 6:198692016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dong L, Li R, Li D, Wang B, Lu Y, Li P, Yu
F, Jin Y, Ni X, Wu Y, et al: FGF10 enhances peripheral nerve
regeneration via the preactivation of the PI3K/Akt
signaling-mediated antioxidant response. Front Pharmacol.
10:12242019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen J, Wang Z, Zheng Z, Chen Y, Khor S,
Shi K, He Z, Wang Q, Zhao Y, Zhang H, et al: Neuron and
microglia/macrophage-derived FGF10 activate neuronal FGFR2/PI3K/Akt
signaling and inhibit microglia/macrophages TLR4/NF-κB-dependent
neuroinflammation to improve functional recovery after spinal cord
injury. Cell Death Dis. 8:e30902017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Farooq M, Khan AW, Kim MS and Choi S: The
role of fibroblast growth factor (FGF) signaling in tissue repair
and regeneration. Cells. 10:32422021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Turner N and Grose R: Fibroblast growth
factor signalling: From development to cancer. Nat Rev Cancer.
10:116–129. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen L, Zhang Y, Yin L, Cai B, Huang P, Li
X and Liang G: Fibroblast growth factor receptor fusions in cancer:
Opportunities and challenges. J Exp Clin Cancer Res. 40:3452021.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hui Q, Jin Z, Li X, Liu C and Wang X: FGF
family: From drug development to clinical application. Int J Mol
Sci. 19:18752018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang SS, Yokomise H, Matsuura N, Gotoh M
and Tabata Y: Novel therapeutic approach for pulmonary emphysema
using gelatin microspheres releasing basic fibroblast growth factor
in a canine model. Surg Today. 44:1536–1541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jin Y, Kim IY, Kim ID, Lee HK, Park JY,
Han PL, Kim KK, Choi H and Lee JK: Biodegradable gelatin
microspheres enhance the neuroprotective potency of osteopontin via
quick and sustained release in the post-ischemic brain. Acta
Biomater. 10:3126–3135. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kempen DH, Lu L, Heijink A, Hefferan TE,
Creemers LB, Maran A, Yaszemski MJ and Dhert WJ: Effect of local
sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone
regeneration. Biomaterials. 30:2816–2825. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lan L, Tian FR, ZhuGe DL, ZhuGe QC, Shen
BX, Jin BH, Huang JP, Wu MZ, Fan LX, Zhao YZ and Xu HL: Implantable
porous gelatin microspheres sustained release of bFGF and improved
its neuroprotective effect on rats after spinal cord injury. PLoS
One. 12:e01738142017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Minardi S, Pandolfi L, Taraballi F, De
Rosa E, Yazdi IK, Liu X, Ferrari M and Tasciotti E: PLGA-Mesoporous
silicon microspheres for the in vivo controlled temporospatial
delivery of proteins. ACS Appl Mater Interfaces. 7:16364–16373.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Q, He Y, Zhao Y, Xie H, Lin Q, He Z,
Wang X, Li J, Zhang H, Wang C, et al: A thermosensitive
heparin-poloxamer hydrogel bridges aFGF to treat spinal cord
injury. ACS Appl Mater Interfaces. 9:6725–6745. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Basso DM, Beattie MS and Bresnahan JC: A
sensitive and reliable locomotor rating scale for open field
testing in rats. J Neurotrauma. 12:1–21. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zheng B, Ye L, Zhou Y, Zhu S, Wang Q, Shi
H, Chen D, Wei X, Wang Z, Li X, et al: Epidermal growth factor
attenuates blood-spinal cord barrier disruption via PI3K/Akt/Rac1
pathway after acute spinal cord injury. J Cell Mol Med.
20:1062–1075. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu WG, Wang ZY and Huang ZS: Bone
marrow-derived mesenchymal stem cells expressing the bFGF transgene
promote axon regeneration and functional recovery after spinal cord
injury in rats. Neurol Res. 33:686–693. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xin DQ, Hu ZM, Huo HJ, Yang XJ, Han D,
Xing WH, Zhao Y and Qiu QH: Schisandrin B attenuates the
inflammatory response, oxidative stress and apoptosis induced by
traumatic spinal cord injury via inhibition of p53 signaling in
adult rats. Mol Med Rep. 16:533–538. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Beenken A and Mohammadi M: The FGF family:
Biology, pathophysiology and therapy. Nat Rev Drug Discov.
8:235–253. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Nakaguchi K, Jinnou H, Kaneko N, Sawada M,
Hikita T, Saitoh S, Tabata Y and Sawamoto K: Growth factors
released from gelatin hydrogel microspheres increase new neurons in
the adult mouse brain. Stem Cells Int. 2012:9151602012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Rong Y, Liu W, Wang J, Fan J, Luo Y, Li L,
Kong F, Chen J, Tang P and Cai W: Neural stem cell-derived small
extracellular vesicles attenuate apoptosis and neuroinflammation
after traumatic spinal cord injury by activating autophagy. Cell
Death Dis. 10:3402019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jia G, Zhang Y, Li W and Dai H:
Neuroprotective role of icariin in experimental spinal cord injury
via its antioxidant, antineuroinflammatory and antiapoptotic
properties. Mol Med Rep. 20:3433–3439. 2019.PubMed/NCBI
|
|
31
|
Lee JY, Kim HS, Choi HY, Oh TH and Yune
TY: Fluoxetine inhibits matrix metalloprotease activation and
prevents disruption of blood-spinal cord barrier after spinal cord
injury. Brain. 135:2375–2389. 2012. View Article : Google Scholar : PubMed/NCBI
|
